Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen-Targeted 18F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide.
Zukotynski KA, Emmenegger U, Hotte S, Kapoor A, Fu W, Blackford AL, Valliant J, Bénard F, Kim CK, Markowski MC, Eisenberger MA, Antonarakis ES, Pienta KJ, Gorin MA, Lubanovic M, Kim J, Pomper MG, Cho SY, Rowe SP.
Zukotynski KA, et al. Among authors: kim ck, kim j.
J Nucl Med. 2021 Oct;62(10):1430-1437. doi: 10.2967/jnumed.120.259069. Epub 2021 Feb 19.
J Nucl Med. 2021.
PMID: 33608426
Free PMC article.
Clinical Trial.